Impact Analysis of Covid-19

The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

Transcriptome refers to a set of all the transcripts present in an individual or a population of cells. Transcripts comprise all types of ribonucleic acid (RNA) molecules namely, messenger RNA (mRNA), ribosomal RNA (rRNA), transfer RNA (tRNA), and other non-coding RNA molecules.

Statistics:

The global transcriptomics technologies market is estimated to account for US$ 15,569.1 Mn in terms of value by the end of 2027.

Global Transcriptomics Technologies Market: Drivers

Approval and launch of microarrays is expected to propel growth of the global transcriptomics technologies market over the forecast period. For instance, in March 2020, Agilent Technologies Inc. launched Agilent GenetiSure Cyto microarrays for prenatal and postnatal research.

Moreover, initiatives to advance personalized medicine are also expected to aid in growth of the market. For instance, in April 2020, Indivumed GmbH, an oncology company, launched the Oncology Alliance for Individualized Medicine, an international collaborative alliance to advance personalized medicine in cancer through IndivuType, the company’s multi-omics database.

Statistics:

North America held dominant position in the global transcriptomics technologies market in 2019, accounting for 39.2% share in terms of value, followed by Europe and Asia Pacific, respectively.

Figure 1: Global Transcriptomics Technologies Market Share (%) Value, By Region, 2019

Transcriptomics Technologies  | Coherent Market Insights

Global Transcriptomics Technologies Market: Restraints

Lack of efficient data analysis tools is expected to hinder growth of the market. With increasing technological advances, there has been a rising concern about data complexity post analysis of transcripts through sequencing platforms. Complex data management is one of the major limitations faced in transcriptome research. The data complexity increases with advances in the subsequent RNA analysis methodologies.

Moreover, complex processes involved in isolation of RNA from the tissue of interest are also expected to limit the market growth.

request-sample

Transcriptomics Technologies Market Report Coverage

Report Coverage Details
Base Year: 2019 Market Size in 2019: US$ 4,625.8 Mn
Historical Data for: 2016 to 2019 Forecast Period: 2020 to 2027
Forecast Period 2020 to 2027 CAGR: 16.4% 2027 Value Projection: US$  15,569.1 Mn
Geographies covered:
  • North America: U.S., Canada
  • Latin America: Brazil, Argentina, Mexico, Rest of Latin America
  • Europe: Germany, U.K., France, Spain, Italy, Russia, Rest of Europe
  • Asia Pacific: China, Japan, India, Australia, South Korea, ASEAN, Rest of Asia Pacific
  • Middle East: GCC Countries, Israel, Rest of Middle East
  • Africa: North Africa, Central Africa, South Africa
Segments covered:
  • By Technology Type: Microarrays, PCR, Gene Regulation Technologies, Next Generation Sequencing.
  • By Application: Clinical Diagnostics, Drug Discovery & Research, Bioinformatics, Comparative Transcriptomics.
Companies covered:

Affymetrix, Inc., Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Danaher Corporation, Illumina, Inc., F. Hoffmann-La Roche Ltd., Life Technologies Corporation, LC Sciences, LLC, and Qiagen N.V.

Growth Drivers:
  • Increasing prevalence of chronic disorders
  • Approval and launch of new products
Restraints & Challenges:
  • High Cost

Global Transcriptomics Technologies Market: Opportunities

Increasing prevalence of cancer is expected to offer lucrative growth opportunities for players in the global transcriptomics technologies market. For instance, according to the American Cancer Society, in 2019, there will be an estimated 1,762,450 new cancer cases diagnosed and 606,880 cancer deaths in the U.S.

Moreover, development of new technologies is also expected to aid in growth of the market. For instance, in December 2019,          PathogenDx, Inc. was awarded two US Patents for Tandem PCR + Microarray Hybridisation technology.

Statistics:

The global transcriptomics technologies market was valued at US$ 4,625.8 Mn  in 2019 and is forecast to reach a value of US$ 15,569.1 Mn by 2027 at a CAGR of 16.4% between 2020 and 2027.

Figure 2: Global Transcriptomics Technologies Market Value (US$ Mn), 2016 – 2027

Transcriptomics Technologies  | Coherent Market Insights

Market Trends/Key Takeaways

Major players in the market are focused on launching new products to expand their product portfolio. For instance, in May 2019, Siemens Healthineers launched its new Atellica CH Enzymatic Hemoglobin A1c Assay to for diagnosing and monitoring diabetes.

Major players in the market are also focused on adopting M&A strategies to expand their product portfolio. For instance, in April 2020, Bio-Rad Laboratories, Inc. acquired Celsee, Inc., a developer of instruments and consumables for the isolation, detection, and analysis of single cells.

Global Transcriptomics Technologies Market: Competitive Landscape

Major players operating in the global transcriptomics technologies market include, Affymetrix, Inc., Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Danaher Corporation, Illumina, Inc., F. Hoffmann-La Roche Ltd., Life Technologies Corporation, LC Sciences, LLC, and Qiagen N.V.

Global Transcriptomics Technologies Market: Key Developments

Major players in the market are focused on adopting partnership strategies to expand their product portfolio. For instance, in March 2020, Illumina, Inc. partnered with IDbyDNA Inc., a metagenomics technology company, for R&D of next-generation sequencing-based workflows.

Major players in the market are focused on approval and launch of new products to expand their product portfolio. For instance, in June 2018, Agilent Technologies Inc. received the U.S. Food and Drug Administration (FDA) approval for its Dako PD-L1 IHC 22C3 pharmDx assay used for determining PD-L1 expression in cervical cancer.

Transcriptomics the study of structures and functions of transcript molecules. Transcripts comprise all types of ribonucleic acid (RNA) molecules namely, messenger RNA (mRNA), ribosomal RNA (rRNA), transfer RNA (tRNA), and other non-coding RNA molecules. Increasing approval and new product launch of microarrays is expected to propel growth of the global transcriptomics technologies market over the forecast period. Furthermore, Increasing prevalence of cardiovascular diseases is expected to offer lucrative growth opportunities for players in the global transcriptomics technologies market.

Key features of the study:

  • This report provides in-depth analysis of the Global Transcriptomics Technologies market  and provides market size (US$ million) and compound annual growth rate (CAGR %) for the forecast period (2020–2027), considering 2019 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends,  regional outlook, and competitive strategy adopted by key players
  • It profiles key players in the Global Transcriptomics Technologies market  based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include, Ethicon, Inc. (Johnson & Johnson), Covidien Plc. (Medtronic Plc.), B. Braun Melsungen AG, Medicon EG, Erbe Elektromedizin GmbH, Conmed Corporation, Carefusion, and Cardinal Health.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
  • The Global Transcriptomics Technologies market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the Global Transcriptomics Technologies market

Detailed Segmentation:

  • Global Transcriptomics Technologies Market, By Technology:
    • Microarrays
    • PCR
    • Gene Regulation Technologies
    • Next Generation Sequencing
  • Global Transcriptomics Technologies Market, By Application:
    • Clinical Diagnostics
    • Drug Discovery & Research
    • Bioinformatics
    • Comparative Transcriptomics
  • Global Transcriptomics Technologies Market, By Region:
    • North America
      • By Technology:
        • Microarrays
        • PCR
        • Gene Regulation Technologies
        • Next Generation Sequencing
      • By Application
        • Clinical Diagnostics
        • Drug Discovery & Research
        • Bioinformatics
        • Comparative Transcriptomics
      • By Country
        • U.S.
        • Canada
    • Latin America
      • By Technology:
        • Microarrays
        • PCR
        • Gene Regulation Technologies
        • Next Generation Sequencing
      • By Application
        • Clinical Diagnostics
        • Drug Discovery & Research
        • Bioinformatics
        • Comparative Transcriptomics
      • By Country
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • By Technology:
        • Microarrays
        • PCR
        • Gene Regulation Technologies
        • Next Generation Sequencing
      • By Application
        • Clinical Diagnostics
        • Drug Discovery & Research
        • Bioinformatics
        • Comparative Transcriptomics
      • By Country
        • U.K.
        • Germany
        • France
        • Spain
        • Italy
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Technology:
        • Microarrays
        • PCR
        • Gene Regulation Technologies
        • Next Generation Sequencing
      • By Application
        • Clinical Diagnostics
        • Drug Discovery & Research
        • Bioinformatics
        • Comparative Transcriptomics
      • By Country
        • China
        • Japan
        • India
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • By Technology:
        • Microarrays
        • PCR
        • Gene Regulation Technologies
        • Next Generation Sequencing
      • By Application
        • Clinical Diagnostics
        • Drug Discovery & Research
        • Bioinformatics
        • Comparative Transcriptomics
      • By Country
        • GCC Countries
        • Israel
        • Rest of Middle East
    • Africa
      • By Technology:
        • Microarrays
        • PCR
        • Gene Regulation Technologies
        • Next Generation Sequencing
      • By Application
        • Clinical Diagnostics
        • Drug Discovery & Research
        • Bioinformatics
        • Comparative Transcriptomics
      • By Country
        • North Africa
        • Central Africa
        • South Africa
  • Company Profiles
    • Affymetrix, Inc. *
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • Agilent Technologies, Inc.
    • Bio-Rad Laboratories, Inc.
    • Danaher Corporation
    • Illumina, Inc.
    • F. Hoffmann-La Roche Ltd
    • Life Technologies Corporation
    • LC Sciences, LLC
    • Qiagen N.V.
  •  “*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objectives and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Technology
      • Market Snippet, By Application
      • Market Snippet, By Country
      • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Key Highlights
    • Product launch
    • PEST Analysis
    • Technological Advancements
    • Regulatory Scenario
    • Mergers and Acquisitions
    • Impact of COVID19 on the market
  4. Global Transcriptomics Technologies Market, By Technology, 2019 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Microarrays
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • PCR
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Gene Regulation Technologies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Next Generation Sequencing
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
  5. Global Transcriptomics Technologies Market, By Application, 2019 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Clinical Diagnostics
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Drug Discovery & Research
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Bioinformatics
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Comparative Transcriptomics
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
  6. Global Transcriptomics Technologies Market, By Region, 2019 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, By Region, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, For Regions, 2017–2026
    • North America
      • Market Size and Forecast, By Technology, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Application, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • U.S.
        • Canada
    • Latin America
      • Market Size and Forecast, By Technology, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Application, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • Market Size and Forecast, By Technology, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Application, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • Germany
        • U.K.
        • France
        • Spain
        • Italy
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast, By Technology, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Application, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • China
        • Japan
        • India
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • Market Size and Forecast, By Technology, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Application, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • GCC Countries
        • Israel
        • Rest of Middle East
    • Africa
      • Market Size and Forecast, By Technology, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Application, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • North Africa
        • Central Africa
        • South Africa
  7. Competitive Landscape
    • Company Profiles
      • Affymetrix, Inc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Agilent Technologies, Inc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Bio-Rad Laboratories, Inc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Danaher Corporation
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Illumina, Inc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • F. Hoffmann-La Roche Ltd.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Life Technologies Corporation
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • LC Sciences, LLC
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Qiagen N.V.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
  8. Section
    • References
    • Research Methodology
    • About us and Sales Contact

*Browse 22 market data tables and 14 figures on “Transcriptomics Technologies Market - Global forecast to 2027”.

Frequently Asked Questions

The Global Transcriptomics Technologies market size was valued at US$ 4,625.8 million in 2019 and is estimated to exhibit a CAGR of 16.4% between 2020 and 2027.
PCR segment held the major market share in 2019 owing to an increasing demand for personalized medicine is expected to propel growth of the market.
Major factor driving the growth of Global Transcriptomics Technologies market during the forecast period increasing product approvals, increasing research & development , and adoption of expansion strategies from major companies.
Major factors hampering the growth of the Global Transcriptomics Technologies market during the forecast period constitutes of lack of efficient data analysis tools.
North America market is expected to generate the highest revenue during the forecast period.
Some of the key players operating in the market are Affymetrix, Inc., Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Danaher Corporation, Illumina, Inc., F. Hoffmann-La Roche Ltd., Life Technologies Corporation, LC Sciences, LLC, and Qiagen N.V.
Existing Clientele

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients

Our Trusted Patner